Associate Professor, Health Systems and Population Health
206-221-3349 | email@example.com
4333 Brooklyn Ave NE, Rm 14-315, Seattle, WA 98195
Prevention effectiveness; outcomes research; comparative effectiveness; neurosurgery; orthopedics, biostatistics; quality of care; clinical trials
Dr. Kopjar joined the University of Washington in 1997 after serving as Head of the Section for Preventive Medicine at the Norwegian Institute for Public Health.
During his time at UW, he has taught courses in Epidemiology and Critical Evidence Appraisal, Health Program Evaluation, Biostatistics and Evidence-based Healthcare Policy. His research interests include: clinical trial design, evaluation of safety and effectiveness of investigational medical products, Real World Evidence (RWE) and outcomes research.
As of 2023, he is listed as an author or co-author on over 500 published original articles, reviews, technical reports and abstracts. He serves as a reviewer for various North American and European medical journals.
Dr. Kopjar’s work has been recognized with more than 30 honors including the 2005 John M. Eisenberg Article-of-the-Year award, 4 North American Spine Society (NASS) Best Paper awards, and the Outstanding Outcomes Research Award by the American Academy of Neurological Surgeons/Congress of Neurological Surgeons Joint Section on Disorders of the Spine and Peripheral Nerves.
In addition to his role at the University of Washington, Dr. Kopjar serves as an expert witness for U.S. and EU legal proceedings, and a consultant biostatistician to the Food and Drug Administration and various medical device, biotech and pharmaceutical companies.
Some of his previous roles include Vice Chairman of Research for AOSpine (part of the AO Foundation), Visiting Consultant to the National Health Service Royal Orthopaedic Hospital in Birmingham, U.K., and Visiting Professor to North American and global universities. He is an elected Fellow of American College of Epidemiology and of the European Academy for Translational Medicine.
From 2014 through 2019, Dr. Kopjar was Director of the University of Washington’s Executive Master of Public Health Program.
From 2014-2019, he served as Distinguished Professor, Department of Orthopaedic Surgery, Chongqing Medical University – one of the largest medical institutions in China.
To date, Dr. Kopjar has served as Principal Investigator, Co-Principal Investigator, Study Director or Lead Biostatistician on more than 100 clinical trials across various therapeutic areas including: infectious diseases, orthopaedics, cardiology, spinal cord injury, bariatric surgery and others. This includes numerous pivotal trials of medical devices in North America and abroad, various Phase 2 and Phase 3 drug studies, and several Post- Market Clinical Follow-up studies. He has participated in federally-funded projects administered through the U.S. Defense Department.
In the 2000’s, Dr. Kopjar served as adviser to two European health ministers.
MD Family Medicine, GP, University of Zagreb (Croatia), 1987
PhD Epidemiology, University of Oslo (Norway), 1996
MS Biostatistics, University of Zagreb (Croatia), 1991